Skip to content
OpenCapital
Get started

Artivion AORT Free cash flow margin

Free cash flow margin at other companies

Abbott logo
AbbottABT
16.3%+0.6pp
Edwards Lifesciences logo
Edwards LifesciencesEW
17.3%—
LeMaitre Vascular logo
LeMaitre VascularLMAT
30.9%+12.7pp
Medtronic logo
MedtronicMDT
14.9%-0.5pp
ITG
Integer HoldingsITGR
5.4%-1.0pp
Merit Medical Systems logo
Merit Medical SystemsMMSI
14.3%+1.3pp

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-24.8%
Enterprise value$1.27B-27.2%
P/E91.5×—
P/S2.3×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Calculated from Artivion’s reported figures.

free cash flow/total revenue=-0.1%

Based on trailing twelve months.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's free cash flow margin?
Artivion (AORT) reported free cash flow margin of -0.1% in Q1 2025.
How has Artivion's free cash flow margin changed year-over-year?
Artivion's free cash flow margin decreased by 104.6% year-over-year, from 2.4% to -0.1%.
What is the long-term trend for Artivion's free cash flow margin?
Over 4 years (2020 to 2024), Artivion's free cash flow margin has grown at a 9.3% compound annual growth rate (CAGR), from 2% to 2.8%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.